Sikkim Journal

Parkinson’s Disease Market Growing With 12.2 Percent of CAGR And Companies Helping Are Novartis, GlaxoSmithKline, Teva Pharmaceutical, Immutep, AbbVie, Adamas Pharmaceuticals, Acorda Therapeutics

 Breaking News
  • No posts were found

Parkinson’s Disease Market Growing With 12.2 Percent of CAGR And Companies Helping Are Novartis, GlaxoSmithKline, Teva Pharmaceutical, Immutep, AbbVie, Adamas Pharmaceuticals, Acorda Therapeutics

September 19
01:18 2019
Parkinson’s Disease Market Growing With 12.2 Percent of CAGR And Companies Helping Are Novartis, GlaxoSmithKline, Teva Pharmaceutical, Immutep, AbbVie, Adamas Pharmaceuticals, Acorda Therapeutics

Parkinson’s Disease
Parkinson’s Disease Market By Type, Mechanism of Cation type, Therapy Type, Drug Type , Route of Administration, End- users (Hospitals, Homecare, Specialty Clinics, Others), Geography

Parkinson’s disease report can help out the clients to make vital decision with accuracy and precisions so that new entrants could get a breakthrough in the market and achieve their goals of gaining maximum profit. The report displays and explains tables, figures, charts and chapters, table of content etc. which provides clear and relevant data to all the clients. The region wise analysis is done in the report that covers revenue, volume, size, value and such valuable data. Industry changing factors for the market segments are encompassed in the parkinson’s disease report. This analysis report covers the growth factors of the worldwide market based on end users.

This significant rise in market value can increase research development initiatives to launching novel therapies. Global parkinson’s disease market is rising gradually to an estimated value of USD 9.7 Billion by 2026 registering a healthy CAGR of 12.2% in the forecast period of 2019-2026.

To Get The Free Sample Of Report, Click On: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-parkinsons-disease-market

Parkinson’s disease is chronic and progressive neurodegenerative disorders that affects dopamine producing neurons in central nervous system. Parkinson’s disease tends to develops in brain over many years. The patient with Parkinson’s disease experience tremor, slow movement, rigid muscle, impaired posture and balance, loss of automatic movements, slurry speech and others.

Moreover, this parkinson’s disease report provides the knowledgeable data of leading market players within the market.  with the help of this parkinson’s disease report, it becomes easy to make decision in the most suitable and profitable ways considering the current situation of the market. This report also makes convenient to forecast the market, its positions and make decisions on the strategies.  The parkinson’s disease research report is the best option for those who want to enhance their growth in the competitive market.

Market Drivers

  • Increase in prevalence rate of parkinson’s disease worldwide
  • Exposure to certain toxin or change in environment may increase the parkinson’s disease
  • The launch of new products and research collaboration are the prime strategies to reinforce the market position
  • Growing in aging population as it affect most commonly in geriatric population
  • Increase in the rate of R&D initiatives is driving parkinson’s disease drug therapeutics market

According to the Clinical Practice Research Data link summary report 2018, it is identified that there were 145,519 prevalence cases of patient with age 20 and above with Parkinson’s disease in UK seen in the year 2018. The estimation incidence cases were 18,461 in patient aged above 45 or over. This significant rise in patient number acts as a driver for the growth of Parkinson’s disease Market.

Access the TOC of the Parkinson’s Disease Market report: https://databridgemarketresearch.com/toc/?dbmr=global-parkinsons-disease-market

 Segmentation: Global Parkinson’s Disease Market

By Type

  • Drug-induced parkinsonism
  • Vascular parkinsonism
  • Normal pressure hydrocephalus (NSA)
  • Corticobasal degeneration (CBD)
  • Progressive supranuclear palsy (PSP)
  • Multiple system atrophy (MSA)
  • Idiopathic Parkinson’s
  • Others

By Mechanism of Cation type

  • Dopamine agonists
  • Monoamine oxidase B (MAO-B) inhibitors
  • Catechol-O-methyltransferase (COMT) inhibitors
  • Adenosine A2 receptor antagonist

By Drug Type

  • Amantadine
  • Safinamide
  • Brivaracetam
  • Pimavanserin
  • Carbidopa and levodopa
  • Rivastigmine tartrate
  • Rotigotine
  • Ferampanel
  • Apomorphine hydrochloride
  • Pramipexole
  • Others

By Therapy

  • Medication
  • Deep brain stimulation
  • Others

By Route of administration

  • Oral
  • Parenteral
  • Sublingual
  • Others

By End Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Geography

North America (U.S., Canada, Mexico)

South America (Brazil, Argentina, Rest of South America)

Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe)

Asia-Pacific ( Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia Pacific)

Middle East & Africa (South Africa, Egypt, Saudi Arabia, United Arab Emirates, Israel, Rest of Middle East & Africa)

Key Developments in the Market:

  • In February 2018, Osmotica Pharmaceuticals plc received FDA approval for Osmolex ER (amantadine hydrochloride) which is an extended release tablet indicated for the treatment of parkinson’s disease and drug-induced extrapyramidal reactions in adult patients
  • In August 2017, Adamas Pharmaceuticals, Inc. received FDA approval Gocovri (amantadine) extended release tablet for the treatment of dyskinesia in patients with parkinson’s disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications

Want Full Report? Make Inquiries For Your Custom Requirements: https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-parkinsons-disease-market

About Us

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing [email protected] . We are content with our glorious 99.9 % client satisfying rate.

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Sopan Gedam
Email: Send Email
Phone: +1-888-387-2818
Address:Office Number 402, Amanora Chambers, Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://databridgemarketresearch.com/reports/global-parkinsons-disease-market/

Related Articles